Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

,Total,Units,P.A.,Higher Education,PNPI,
Units that perform R+D in Biotechnology,1.332,1.133,120,67,12,
%Units according to biotechnology used: Genetic code,41,33,88,87,33,
%Units according to biotechnology used: Functional units,48,41,89,91,50,
%Units according to biotechnology used: Cellular and tissue culturing and engineering,31,24,74,82,50,
%Units according to biotechnology used: Bioprocesses,53,50,61,93,42,
%Units according to biotechnology used: Sub-cellular organisms,14,6,56,72,33,
%Units according to biotechnology used: Bio-computing,31,24,69,85,8,
%Units according to biotechnology used: Nanobiotechnology,19,13,50,70,8,
%Units according to biotechnology used: Other,14,14,8,18,8,
Units in which biotechnology activities are:  Main and/or exclusive,647,603,33,5,6,
Units in which biotechnology activities are: A secondary line of business,252,173,39,38,2,
Units in which biotechnology activities are: A tool necessary for production,433,357,48,24,4,
%Units by field(s) of ultimate application of biotechnology use: Human health,51,45,78,91,58,
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,20,18,15,67,8,
%Units by field(s) of ultimate application of biotechnology use: Food products,32,31,20,79,8,
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:,24,22,19,73,25,
%Units by field(s) of ultimate application of biotechnology use: Environment,17,14,22,72,17,
%Units by field(s) of ultimate application of biotechnology use: Industry,15,12,12,67,8,
Personnel in R&D in biotechnology (no. of persons),40.018,11.510,13.944,14.415,149,
Personnel in R&D in biotechnology (no. of persons): Researchers,26.603,6.202,8.687,11.634,80,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,13.415,5.308,5.257,2.781,69,
Personnel in R&D in biotechnology (no. of persons): women,22.240,6.389,8.590,7.165,96,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,13.936,3.304,5.040,5.545,47,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,8.305,3.086,3.550,1.620,49,
Personnel in R&D in biotechnology (FTE),27.550,6,8.236,9,10.492,6,8.726,3,94,8,
Personnel in R&D in biotechnology (FTE): Researchers,17.572,9,4.596,1,6.124,4,6.798,1,54,3,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,9.977,7,3.640,8,4.368,2,1.928,2,40,5,
Personnel in R&D in biotechnology (FTE): women,15.792,1,4.698,5,6.519,9,4.509,64,7,
Personnel in R&D in biotechnology (FTE): (women) Researchers,9.524,4,2.512,5,3.603,3,3.374,3,34,3,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,6.267,7,2.186,2.916,6,1.134,7,30,4,
Internal expenditure on R&D (thousands of euros),1.783.011,769.431,596.928,411.163,5.489,
1) By nature of the expense: Current expenses,1.673.710,719.715,567.086,381.526,5.383,
1.1) Remuneration to researchers,677.784,221.447,225.782,228.981,1.573,
1.2) Remuneration to technicians and assistants,290.584,122.809,107.902,58.884,989,
1.3) Other current expenses,705.342,375.459,233.402,93.661,2.820,
2) By nature of the expense: Capital expenses,109.301,49.715,29.842,29.637,106,
2.1) Land and buildings,18.585,9.521,3.511,5.553,0,
2.2) Equipment and instruments,78.285,30.466,25.115,22.598,106,
2.3) Acquisition of specific R+D software,4.139,1.810,1.014,1.314,1,
2.4) Otros productos de propiedad intelectual específicos para I+D,8.292,7.919,202,172,0,
1.1) By origin of the funds: Own funds,639.755,490.913,69.873,78.383,585,
1.2) By origin of the funds: From companies,189.495,82.548,77.770,28.349,828,
1.3) By origin of the funds: Public Administration funds,737.076,96.809,379.076,258.952,2.239,
1.4) By origin of the funds: From Universities,2.962,197,1.380,1.309,75,
1.5) By origin of the funds: From non profit private institutions,24.088,4.766,11.426,6.679,1.217,
1.6) By origin of the funds: Foreign funds,189.635,94.197,57.401,37.492,545,
Purchase of services R & D in Biotechnology to (thousands of euros),153.607,120.281,26.850,6.101,375,
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain,98.024,69.564,22.379,5.769,312,
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad,55.583,50.718,4.470,332,63,
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital,47,45,59,58,75,
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,12,3,12,25,
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources,20,16,41,40,33,
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,16,14,28,36,25,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,19,16,33,43,33,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels,20,18,30,40,25,
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,15,15,11,11,33,
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,37,42,34,42,
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost,53,52,61,61,58,
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,20,20,19,25,
%Units that have requested biotechnology patents in Biotechnology,21,15,45,75,8,
Number of patents requested,1.785,681,555,548,1,
Notas:
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute